Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
We invite all authors to submit online any new manuscripts that are to be considered for publication. Please use the following URL:
For further information or questions about articles in the peer-review process, please contact Jane Taylor at firstname.lastname@example.org
For technical information on using Manuscript Central, contact Author Services at
Instructions for Authors
Cellular Reprogramming is a peer-reviewed journal that publishes original research articles, review papers, and short communications. Contributions are welcome in the fields of oocyte maturation, activation, fusion, cell cycle, gene expression, embryo culture, and embryo transfer as it relates to nuclear transfer; embryonic stem cells, primordial germ cells, and somatic cell lines, including their genetic modification (as it relates to nuclear transfer); and production of pharmaceutical proteins in milk by cloning, and tissue and organ therapy (xenotransplantation) using cloned animals and germ line gene therapy.
The Journal will also publish LiteratureWatches, Web-Watches, Point/Counterpoints, News and Comments, including Meetings, and Book Reviews.
Manuscripts submitted to this Journal must not be under consideration elsewhere and must not have been previously published.
Preparation of Manuscript
All submitted manuscripts will be processed through plagiarism detection software. Plagiarized manuscripts will be rejected immediately.
It is incumbent upon the submitting author to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. Once a paper is accepted for publication, changes in authorship – including the page proof stage – are NOT permitted. Changes in authorship after publication are strictly prohibited.
The editor acknowledges that all animals are creatures of great value and remarkable complexity. The use of animals in research can contribute uniquely to the advancement of scientific knowledge, and thus, ultimately, to improvements in human health or welfare of humans and animals. Please include in your manuscript a description of the regulatory framework that monitored the animal welfare in your institution.
Manuscripts should be submitted double-spaced in Microsoft Word. Leave ample margins on both sides, top and bottom.
When uploading your paper be prepared to enter:
• A running title of 45 characters maximum including spaces.
• Supply an abstract of about 200 words, stating the aims, results, and conclusions drawn from the study. Reference citations are not permitted in the abstract.
• Your submission should display the following in this order: Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Author Disclosures, and the tables and figure legends. Results and Discussion should be separate sections.
• Authors should review the style and clarity of their manuscripts with colleagues before submission.
Please follow the protocol described herein to avoid delay in publication. Authors should note that manuscripts may be edited if needed to ensure clear grammatical English usage. The editors welcome suggestions concerning potential reviewers.
Submission of Brief Reports is also welcome. A Brief Report should communicate new methodological information in the fields of mammalian cloning, transgenics, and cell and tissue therapy. It should be divided as follows: Abstract (no more than 200 words), Introduction, Materials and Methods, Results, Discussion (please note that in Brief Reports, Results and Discussion can be combined), Acknowledgments, Disclosures, References, and tables and figure legends.
The whole report should be composed of no more than four journal pages (about 3,000 words), including tables and figures. For general rules, please follow the guidelines given for Research Articles.
Letters to the Editor(s)
Letters to the Editor(s) are welcomed, but with a 500 word limit and no more than one (1) table OR figure, and with a maximum of four (4) references.
Manuscript keywords (search terms): On the title page of the manuscript, include a minimum of three (3), maximum of six (6), search terms that will aid in the discoverability of the article in indexing services and search engines. These terms may or may not be different from the terms you selected for the peer review process and areas of expertise. You will be asked to retype these search terms in the submission form when uploading your manuscript. These keywords will be included in the published article. If the search terms entered do not match the manuscript, the manuscript will serve as the default.
Keywords (Areas of Expertise)
To facilitate the peer review process, select 4-6 keywords from the drop-down list of pre-selected terms when submitting your manuscript. These keywords will assist in the selection of skilled reviewers in the field for the purposes of peer review.
Tables and Illustrations
Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. Explain abbreviations used in the body of the table in footnotes. If the table is taken from a copyrighted publication, credit must be given in a footnote.
A legend should be supplied for each illustration, and all legends should be typed (double-spaced) and numbered consecutively at the end of the manuscript. Figures should be numbered in the order cited in the text. Images should not show the name of a manufacturer.
Please follow these guidelines when submitting figures:
• Do not include any illustrations as part of your text file.
• Do not prepare any figures in Word as they are not workable.
• Line illustrations must be submitted at 900 DPI.
• Halftones and color images should be submitted at a minimum of 300 DPI.
• Adobe is the preferred software.
• PowerPoint and Excel files cannot be uploaded.
• Save art as either TIFFor EPS files. Avoid submitting JPEG files.
• Color art must be saved as CYMK not RGB.
All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Disclosure section.
Funding Information (required)
Include the full name (do not abbreviate) of any funding agency(ies)/institutions(s) and list all associated grant numbers. Ensure the accuracy of grant numbers and be sure to include all grants. If the work did not receive funding, this must be clearly stated.
All references should be cited by authors and dates within the text (citations are not permitted in the abstract):
i.e. The ribosomal RNA (rrn) operons in E. coli contain single copies of each of the 16S, 23S, and 5S r(RNA) genes (Pace, 1973).
If more than two authors are involved, use et al. after the first author’s name:
i.e. (Wells, et al., 1997).
If several article by the same authors are cited in one sentence, use a lower case letter designation to indicate the individual papers:
i.e. (Dunn and Studier, 1973a, 1973b). Use same designation in reference list.
All references in the bibliography should be double spaced and listed in alphabetical order at the end of the paper. References should include the complete titles of cited papers and all authors:
Journal citation: Pace, N. (1973). Structure and synthesis of the ribosomal ribonucleic acid of prokaryotes. Bacteriol. Rev. 37, 562–603.
Book citation: Brosius, J. (1987). Expression vectors employing l, trp, lac, and lpp-derived promoters. In Vectors, a Survey of Molecular Cloning Vectors and Their Uses. R.L. Rodriguez and D.T. Denhardt, eds. (Butterworth Publishers, Stoneham, MA) pp. 205–225.
When data from an unpublished source are given, supply the researcher’s name. If the work is in press, give the journal in which it is to be published or the name of the publisher. Abbreviations of journal names should follow the style of MEDLINE.
The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure, should read “reprinted by permission from Jones et al.” and list the appropriate reference. All permissions listings must be shown in the manuscript—they cannot be entered on proofs.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740-2100; fax: (914) 740-2101; e-mail: email@example.com on-line: www.liebertpub.com
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.org.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.